CD8A and neoplasm: After learning that there was an immune infiltration difference between HPV+ and HPV- samples, we performed tumor immune infiltration of bulk RNA sequencing samples with survival information by CIBERSORT and found significantly longer survival for samples infiltrated with CD8+ cells and B cells.